lifenews.com
2025-10-13
Republican senators are calling on one of the nation's most influential health agencies to reconsider its recent decision to expand access to abortion drugs. The U.S. Food and Drug Administration (FDA) decided late last month to quietly approve production of a generic version of the abortion drug mifepristone, despite having previously pledged to conduct a thorough review of the pill's safety. On Thursday, a coalition of 51 GOP senators issued a letter to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, urging the officials to suspend approval of the generic abortion drug expansion and reinstate safeguards on mifepristone's prescription and use that were previously removed while the FDA conducts its abortion drug review.
"Under your leadership, we have seen a strong commitment to reevaluating the policies that affect the most vulnerable among us -- the unborn," the senators wrote, referring to Makary's promise to conduct a mifepristone review. "But the work is far from over. The 'abortion-on-demand' culture enabled by the Biden-Harris administration's removal of critical safeguards on the only FDA-approved abortion regimen is currently the biggest threat to unborn life in America today."
When mifepristone was first approved by the FDA in 2000, the agency placed numerous restrictions around the drug's prescription and use: three in-person physician visits were required before the drug could be prescribed, the drug could only be prescribed by a physician, it had to be dispensed and consumed in the physician's office, and a follow-up visit was required, as was reporting of any complications. In 2016, then-President Barack Obama eliminated the requirement that the abortion drug be prescribed by a physician and consumed in-office, as well as the mandatory follow-up visit and reporting of complications, and lowered the number of in-person physician visits prerequisite to prescription. Under then-President Joe Biden in 2023, the FDA did away with most of the remaining safeguards, requiring no in-person physician visits, no physician to prescribe the drug, no dispensing or consuming the drug in-office, no follow-up visit, and no reporting of complications.
Criminals Running Illegal Abortion Biz Could Spend 20 Years in Prison for Killing Babies by Steven Ertelt
Man Who Spiked Wife's Drink With Abortion Pill to Kill Their Baby Now Headed to Prison by Dave Andrusko